HYPOSENSITIZATION THERAPY
\hˌa͡ɪpə͡ʊsˌɛnsɪta͡ɪzˈe͡ɪʃən θˈɛɹəpi], \hˌaɪpəʊsˌɛnsɪtaɪzˈeɪʃən θˈɛɹəpi], \h_ˌaɪ_p_əʊ_s_ˌɛ_n_s_ɪ_t_aɪ_z_ˈeɪ_ʃ_ə_n θ_ˈɛ_ɹ_ə_p_i]\
Sort: Oldest first
-
Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity.
By DataStellar Co., Ltd
Word of the day
Proto Oncogene Proteins c erbB 2
- cell surface protein-tyrosine kinase that is found to be overexpressed in significant number adenocarcinomas. It has extensive homology can heterodimerize EGF EPIDERMAL GROWTH FACTOR), 3 receptor (RECEPTOR, 3) and the 4 receptor. Activation of erbB-2 receptor occurs during heterodimer formation with a ligand-bound erbB family members. EC 2.7.11.-.